Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Deglycyrrhizinated licorice (DGL)

Deglycyrrhizinated Licorice (DGL) · also known as DGL, Deglycyrrhizinized licorice, Chewable licorice tablets

In animal studies, deglycyrrhizinated licorice (DGL) can increase mucus-secreting cells in the stomach, and a specific deglycyrrhizinated extract can also improve intestinal barrier markers. There is no direct human evidence of increased mucosal mucin or of a protective film forming over the stomach and esophagus.

Typical dose: Chewable tablets, 380–760 mg per dose, chewed thoroughly and swallowed 20 minutes before main meals or when acid reflux or heartburn starts.
Absorption and forms: DGL usually comes as chewable tablets, and chewing helps the tablet break down and mix with saliva. There is no reliable evidence that salivary amylase is needed to form a protective hydrogel, and chewables should not be regarded as the only effective form.

Clinical uses and human evidence

Stomach lining protection and indigestion

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Raveendra 2012 · Evid Based Complement Alternat Med · RCT · n=50 — An Extract of Glycyrrhiza glabra (GutGard) Alleviates Symptoms of Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Study
  2. Bardhan 1978 · Gut · RCT · n=96 — Clinical trial of deglycyrrhizinised liquorice in gastric ulcer

Mechanisms of action

Epithelial tight junction (ZO-1 / Occludin) reinforcement and barrier repair

★★★☆☆Mechanism evidence: grade CSecondary target

One animal study of the intestinal barrier showed that a specific deglycyrrhizinated licorice flavonoid extract can improve intestinal permeability and regulate tight junction proteins. This evidence comes from a specific extract and an intestinal model, so it cannot be applied directly to all DGL chewable tablets or to the human stomach and esophagus.

References (1)
  1. Murugan 2022 · Rat colitis study: a specific deglycyrrhizinated licorice flavonoid extract improved intestinal permeability and regulated ZO-1, Occludin and Claudin-2

Secretion of intestinal mucin (MUC2) and the protective mucus gel layer

★☆☆☆☆Mechanism evidence: grade DPrimary target

Animal studies show that deglycyrrhizinated licorice can increase labeled mucus-secreting cells in gastric glands, and the authors speculated that it promotes mucus formation. However, there is no reliable human evidence of increased intestinal MUC2 or gastric MUC5AC, or of prostaglandins directly activating goblet cells.

References (2)
  1. Van Marle 1981 · Rat study: DGL increased labeled mucus-secreting cells in gastric glands; the authors speculated that it promotes mucus formation
  2. Literature search · No direct study: no reliable human study has shown that DGL specifically induces intestinal MUC2 or gastric MUC5AC, or directly activates goblet cells through prostaglandins

Safety and drug interactions

Most of the glycyrrhizic acid has been removed from DGL (residual content below 1%), but reduced does not mean entirely free of glycyrrhizic acid. Depending on the residual amount, dose and duration of use, fluid and sodium retention, low potassium or raised blood pressure may still occur. Regular licorice root that has not been deglycyrrhizinated must never be taken continuously in high doses over the long term.
Open in the interactive app ›